Literature DB >> 32242291

Cerebrospinal fluid MOG-antibodies in anti-NMDA receptor encephalitis with leptomeningeal enhancement.

Eiichiro Amano1, Akira Machida2, Naomi Kanazawa3, Takahiro Iizuka3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32242291     DOI： 10.1007/s10072-020-04343-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  3 in total

1.  A case of concurrent anti-myelin oligodendrocyte glycoprotein antibody-associated myelitis and subacute combined degeneration.

Authors:  Keisuke Mizutani; Keita Sakurai; Toshiyuki Takahashi; Hiroyuki Yuasa
Journal:  Neurol Sci       Date:  2020-11-20       Impact factor: 3.307

2.  Clinical characteristics of MOG antibody disease: two case reports.

Authors:  Yujia Guan; Zunwei Zhang; Mingming Li; Miao Shi; Hui Deng
Journal:  Neurol Sci       Date:  2021-02-10       Impact factor: 3.307

Review 3.  Clinical Features and Imaging Findings of Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disorder (MOGAD).

Authors:  Yunjie Li; Xia Liu; Jingxuan Wang; Chao Pan; Zhouping Tang
Journal:  Front Aging Neurosci       Date:  2022-03-15       Impact factor: 5.750
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.